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Abstract
Background: Diabetic nephropathy (DN) has been recognized as the leading cause of end-stage renal disease.
Resveratrol (RSV), a polyphenolic compound, has been indicated to possess an insulin-like property in diabetes. In
the present study, we aimed to investigate the renoprotective effects of RSV and delineate its underlying
mechanism in early-stage DN.
Methods: The protective effects of RSV on DN were evaluated in streptozotocin (STZ)-induced diabetic rats.
Results: The plasma glucose, creatinine, and blood urea nitrogen were significantly elevated in STZ-induced
diabetic rats. RSV treatment markedly ameliorated hyperglycemia and renal dysfunction in STZ-induced diabetic
rats. The diabetes-induced superoxide anion and protein carbonyl levels were also significantly attenuated in RSV-
treated diabetic kidney. The AMPK protein phosphorylation and expression levels were remarkably reduced in
diabetic renal tissues. In contrast, RSV treatment significantly rescued the AMPK protein expression and
phosphorylation compared to non-treated diabetic group. Additionally, hyperglycemia markedly enhanced renal
production of proinflammatory cytokine IL-1b. RSV reduced IL-1b but increased TNF-a and IL-6 levels in the
diabetic kidneys.
Conclusions: Our findings suggest that RSV protects against oxidative stress, exhibits concurrent proinflammation
and anti-inflammation, and up-regulates AMPK expression and activation, which may contribute to its beneficial
effects on the early stage of DN.
Introduction
Diabetes mellitus (DM), mainly characterized by recur-
rent hyperglycemia, had become one of the chronic dis-
orders derived from insulin deficiency or resistance in
the developed countries. As the high blood glucose level
in diabetes persisted and progressed without appropriate
medical care, relative secondary disorders involving
atherosclerosis, retinopathy, nephropathy, neuropathy,
stroke, and foot ulcer would individually develop with
an insidious onset, which could eventually be life-threa-
tening. Diabetic nephropathy (DN), the second most
prevalent diabetes-associated complication inferior to
cardiovascular disorders, impaired the renal function of
DM patients and therefore cost appreciable medical
labor and resource for DN management annually. Histo-
logically featured by thickening of basement membrane,
expansion and nodular aggregation of mesangial matrix
(the Kimmelstiel-Wilson lesions) and sclerosis in glo-
meruli, DN could be multifactorial in the pathogenesis.
In these risk factors, hyperglycemia was currently
regarded as one of the leading causes in the progression
of DN. Accumulating evidence also suggested the devel-
opment of DN was associated with the activation of sev-
eral stress-sensitive signal pathways, including nuclear
factor kappa B (NF-B) and mitogen-activated protein
kinase (MAPK) [1-4]. Additionally, it was reported that
* Correspondence: lisahung@mail.cgu.edu.tw
1Department and Graduate Institute of Biomedical Sciences, College of
Medicine, Chang Gung University, Tao-Yuan, Taiwan
Full list of author information is available at the end of the article
Chang et al. Journal of Biomedical Science 2011, 18:47
http://www.jbiomedsci.com/content/18/1/47
© 2011 Chang et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.both oxidative stress [5-8] and proinflammatory cyto-
kines [9,10] detrimentally accelerated the pathological
process of DN. Adenosine monophosphate-activated
protein kinase (AMPK), a regulator of cellular energy
homeostasis, was recently identified to play an impor-
tant role in DN [11]. Decreased phosphorylation of
AMPK was contributed to hyperglycemia-associated
renal enlargement. Further studies indicated that sup-
pression of AMPK activity was linked with oxidative
stress [12] and inflammatory response [13]. Reversion of
AMPK activity could ameliorate oxidative damage [14]
and inflammation [15]. Thus, attention has been drawn
to the modulation of AMPK signal transduction to
attenuate DM-affected renal dysfunction.
Resveratrol (trans-3,4’,5-trihydroxyestilbene, RSV), one
naturally existing polyphenolic compound rich in grapes
and several plants, was characterized as a potently free
radical scavenger and antioxidative agent. Besides, RSV
was pronounced to possess both cardioprotective
[16-18] and antidiabetic benefits [19,20]. A vast majority
of reports also supported that RSV displayed a hypogly-
cemic effect on DM animal models via AMPK stimula-
tion [21-24]. In DN studies, RSV was proved to mitigate
renal dysfunction and oxidative stress in type 1 diabetic
rats [5,25].
One recent research investigated the AMPK-stimulat-
ing effect of RSV on the early stage of DN [26]. It was
also reported that RSV did not remarkably alter the
messenger RNA and protein levels of inflammation-reg-
ulatory cyclooxygenase (COX) in the diabetic rat kidneys
[27]. Additionally, RSV activated NF-B in mesangial
cells under a precondition of cytokine exposure [28].
Therefore, it still required further survey to delineate
the precise mechanisms of RSV action on DN.
Considering the hypoglycemic, antioxidative, inflam-
matory modulation and AMPK-up-regulating effects of
RSV on type 1 DM, we designed this study to realize
the therapeutic effects and associated mechanisms of
RSV on streptozotocin (STZ)-induced DM rats. The oxi-
dative stress, proinflammatory cytokines, and several cel-
lular stress-activated signal pathways were
simultaneously evaluated in diabetic rats. Our results
s h o wt h er e n o p r o t e c t i v ee f f e c t so fR S Vm a yc o n t r i b u t e
by its antioxidative and AMPK-up-regulating abilities
and, to our interest, found that RSV significantly aug-
mented inflammatory response in diabetic kidney by ele-
vating several cytokines like tumor necrosis factor a
(TNF-a) and interleukin 6 (IL-6), despite its ameliora-
tive effect on IL-1b cytokine level in DN.
Methods
Animals
This survey was submitted to the rules written in the
Guide for the Care and Use of Laboratory Animals,
published by the US National Institutes of Health (NIH
publication No. 85-23, revised 1996). Experiments were
performed on male Long-Evans rats (6-7 weeks old,
220-250 g), maintained in the animal center of Chang
Gung University within an environment-controlled
room (ambient temperature of 25 ± 1°C and a light-
dark period of 12 h) with free access to normal chow
and water. The experimental animals were randomly
assigned to two groups, the non-diabetic rats (control,
CON) and STZ-induced diabetic rats (STZ-DM). In the
diabetic group, male Long-Evans rats were fasted and
anesthetized by intraperitoneal injection of pentobarbital
at a dosage of 65 mg/kg. Freshly prepared STZ (65 mg/
kg, Sigma-Aldrich, St. Louis, MO, USA) solution was
then injected intravenously into the femoral vein of ani-
mals. The experimental rats with symptoms as polypha-
gia, polydipsia, and polyuria together with a blood
glucose level above 300 mg/dl were considered diabetic.
The blood glucose level was determined by the glucose
oxidase method (chemistry analyzer; Auto Analyzer
Quik-Lab, Ames, Spain). Two weeks after the onset of
DM, the DM rats were further divided into three sub-
groups concomitantly treated with vehicle (STZ-DM),
RSV 0.1 mg/kg (DM-R0.1) or RSV 1 mg/kg (DM-R1)
for 7 consecutive days. RSV (Sigma-Aldrich, St. Louis,
MO, USA) was suspended in 0.9% saline solution and
administrated by oral gavage. At the end of RSV treat-
ment course, the rats were euthanized and sacrificed.
All the renal tissues and blood samples were preserved
at -80°C.
Western blot analysis
Tissue lysates were extracted from renal tissues in
accordance to previously published procedure with
appropriate modifications [16]. Briefly, dissected renal
tissues were segmented into small pieces and pestled
with liquid nitrogen. The grinding renal tissue samples
were lysed with ice-cold lysis buffer containing 50 mM
Tris-HCl (pH 7.4), 50 mM glycerophosphate, 20 mM
sodium fluoride, 2 mM sodium orthovanadate, 2 mM
Ethylenedinitrilotetraacetic acid (EDTA), 1 mM phenyl-
methanesulfonyl fluoride (PMSF), and 1% 2-mercap-
toethanol. The homogenates were centrifuged at 12,000
g for 10 min at 4°C and the supernatants were isolated
for Western blot preparation.
After protein determination, the samples were then
separated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) on 10 or 15% polyacryla-
mide denaturing gels and thus transferred onto polyvi-
nylidene difluoride (PVDF) membranes, which were
then probed with monoclonal antibodies with recom-
mended dilution of manganese superoxide dismutase
(MnSOD), copper-zinc SOD (CuZnSOD) (Upstate Bio-
technology, Lake Placid, NY, USA), NF-B, Erk,
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Page 2 of 10phospho-Erk (Thr202/Tyr204), p38, phospho-p38
(Thr180/Tyr182) (Chemicon, Temecula, CA, USA), JNK,
phospho-JNK (Thr183/Tyr185) (Cell Signaling Technol-
ogy, Cell Signaling, Boston, MA, USA), Akt, phospho-
Akt (Thr308) (Santa Cruz), AMPK and phospho-AMPK
(Thr172) (Chemicon), respectively. Following the incu-
bation with appropriate secondary horseradish peroxi-
dase (HRP)-conjugated IgG antibodies, the
chemiluminescence was thus performed. The obtained
protein bands were scanned and quantified with the aid
of Image J software (NIH, Bethesda, MD, USA).
Oxidative stress and proinflammatory cytokines analysis
The renal production of superoxide anion was measured
by modified lucigenin-enhanced chemiluminescence. The
chemical specificity of this light-yielding reaction for
superoxide anion has previously been described in detail
[29]. The extent of lipid peroxidation was determined
using the modified thiobarbituric acid reactive substances
(TBARS) method, which was also reported previously [29].
The level of protein carbonyl group was measured by the
2,4-dinitrophenylhydrazine (DNPH) method with slight
modification, as described previously [30]. Furthermore,
proinflammatory cytokines in renal tissues, including
TNF-a,I L - 1 b and IL-6, were determined by using com-
mercially acquired ELISA kits (R&D Systems, Minneapolis,
MN) according to the manufacturer’si n s t r u c t i o n s .
Histopathological analysis
To assess the renal pathology in the diabetic animal mod-
els, periodic acid-Schiff (PAS) stain was performed as
described previously [31]. In brief, the kidneys were imme-
diately perfused with 4% paraffinparaformaldehyde after
the decapitation of animals. The fixed renal tissues were
paraffin-embedded and cross-sectioned into 2 μmt h i c k -
ness and periodic acid, Schiff’s reagent and hematoxylin
were further performed. After dehydration, the histopatho-
logical changes of stained glomeruli were observed and
elucidated by the veteran pathologist with expert guidance.
Biological analysis
All the biological measurements were determined using
commercially available kits. The blood samples from
experimental animals were obtained following by over-
night fasting. Plasma glucose levels were evaluated on
the basis of the glucose oxidase-catalyzed reaction
(chemistry analyzer; Auto Analyzer Quik-Lab, Ames,
Spain). Plasma insulin levels were measured by a sand-
wich enzyme-linked immunosorbent assay (ELISA)
method (Mercodia, Uppsala, Sweden). Plasma choles-
terol, triglyceride, creatinine, and blood urea nitrogen
(BUN) levels were determined under the instructions
provided by the manufacturer (Ransel kit, Randox, UK).
Statistical analysis
All values were expressed as mean ± standard error
(SE). Following the performance by one-way analysis of
variance (ANOVA), the difference of experimental data
was analyzed by using Student t test. P < 0.05 was con-
sidered to be significant.
Results
Effects of RSV on the body weight and biochemical
parameters of the STZ-DM rats
As shown in Table 1, blood glucose level was signifi-
cantly higher in STZ-induced type 1 diabetic rats than
in the normal controls. It was also observed that both
body weight and plasma insulin levels were significantly
decreased in the diabetic group when compared with
the non-diabetic controls. Besides, the plasma choles-
terol and triglyceride levels were significantly elevated in
the diabetic rats in comparison with the non-diabetic
controls. Giving RSV treatment with two dosages (0.1
and 1 mg/kg/day for 7 days) significantly ameliorated
the body weight loss, hyperglycemia, hypoinsulinemia,
and hyperlipidemia in STZ-DM rats, but the body
weight, plasma glucose, insulin, and triglyceride levels in
RSV-treated diabetic rats still remained significantly
higher in comparison with normal control.
Table 1 The biochemical parameters of CON, STZ-DM, DM-R0.1 and DM-R1 rats
CON (n = 11) STZ-DM (n = 7) DM-R0.1 (n = 11) DM-R1 (n = 15)
Body weight (g) 420.77 ± 8.88 280.29 ± 9.41* 330.77 ± 9.45*
† 312.81 ± 10.55*
†
Plasma glucose (mg/dl) 137.15 ± 10.86 566.33 ± 45.24* 444.17 ± 22.90*
† 376.48 ± 35.56*
†
Plasma insulin (μg/l) 2.00 ± 0.28 0.11 ± 0.06* 0.78 ± 0.25*
† 0.86 ± 0.12*
†
Plasma cholesterol (mg/dl) 67.30 ± 9.63 111.13 ± 16.98* 59.51 ± 7.16
† 48.05 ± 5.64
†
Plasma triglycerides (mg/dl) 88.27 ± 11.41 166.41 ± 35.43* 55.84 ± 7.47*
† 63.52 ± 9.20
†
Blood urea nitrogen (mg/dl) 16.27 ± 0.94 25.01 ± 3.90* 19.97 ± 1.52* 21.73 ± 1.72*
Plasma creatinine (mg/dl) 0.37 ± 0.04 0.59 ± 0.10* 0.41 ± 0.04
† 0.48 ± 0.04
Values were expressed as means ± standard error (n = 7~15 per group). CON: non-diabetic control, STZ-DM: streptozotocin-induced diabetes, DM-R0.1: DM
treated with RSV (0.1 mg/kg/day) for 7 days, DM-R1: DM treated with RSV (1 mg/kg/day) for 7 days.
*: P < 0.05 vs. control, †: P < 0.05 vs. STZ-DM, ‡: P < 0.05 vs. DM-R0.1.
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STZ-DM rats
It appeared that plasma creatinine and BUN levels were
significantly increased in the diabetic rats (Table 1).
Only treatment with the dosage of 0.1 mg/kg RSV
markedly ameliorated the plasma creatinine level.
There was no remarkable attenuation on the BUN
levels after RSV treatment in the DM rats. The BUN
levels in RSV-treated diabetic rats still remained signifi-
cantly higher in comparison with normal control.Addi-
tionally, the renal tissue stained by Periodic acid and
Schiff’s solution appeared normal glomeruli in the renal
cortex of non-diabetic controls (Figure 1A). In contrast,
it was shown that diabetes-induced histopathological
changes in the renal tissues, including the expansion of
mesangial matrix and thickening of glomerular base-
ment membrane, to a mild extent (Figure 1B). After
RSV treatment, enlargement of mesangia in glomeruli
was mildly attenuated in the diabetes-affected renal tis-
sues (Figure 1C, D).
RSV ameliorated oxidative stress in the STZ-induced type
1 diabetic kidneys
The indicators of oxidative stress including the contents
of superoxide anion, malondialdehyde, and carbonyl
protein, and protein expressions of MnSOD and CuZn-
SOD were all significantly enhanced in the nephritic tis-
sues of STZ-DM rats than that in the normal control
(Figure 2). After RSV administration, the superoxide
anion and protein carbonyl levels were significantly
decreased in the diabetic rats (Figure 2A, C). Addition-
ally, it seemed that RSV did not alleviate lipid peroxida-
tion when compared to the non-treated DM rats (Figure
2B). Lipid peroxidation was significantly increased in
RSV-treated diabetic groups when compared to normal
control. Although MnSOD and CuZnSOD showed a
A B
C D
Figure 1 The effects of RSV on mesangial expansion in DN. Photomicrographs of rodent glomeruli sections of CON (A), STZ-DM (B), DM-R0.1 (C)
and DM-R1 (D) groups were represented at × 400 magnification from periodic acid-Schiff-stained kidney. CON: non-diabetic control, STZ-DM:
streptozotocin-induced diabetes, DM-R0.1: DM treated with RSV (0.1 mg/kg/day) for 7 days, DM-R1: DM treated with RSV (1 mg/kg/day) for 7 days.
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Figure 2 The effects of RSV on superoxide anion production, lipid peroxidation, protein carbonyl level, MnSOD and CuZnSOD protein
expressions in the renal tissues of STZ-DM rats. (A) Superoxide anion content was measured by lucigenin-enhanced chemiluminescence. (B)
Lipid peroxidation was determined using the modified thiobarbituric acid reactive substances method. (C) Protein carbonyl level was evaluated
by 2,4-dinitrophenylhydrazine method. (D) Equal amounts of proteins were resolved on 10 and 15% SDS-PAGE and blotted with MnSOD and
CuZnSOD antibodies, respectively. The blots were shown at the top and the quantified ratios were shown at the bottom. Results were expressed
as means ± standard error (n = 5 per group). *: P < 0.05 vs. control, †: P < 0.05 vs. STZ-DM, ‡: P < 0.05 vs. DM-R0.1, RLU: relative light unit, LPO:
lipid peroxidation, PCL: protein carbonyl level, SOD: superoxide dismutase, CON: non-diabetic control, STZ-DM: streptozotocin-induced diabetes,
DM-R0.1: DM treated with RSV (0.1 mg/kg/day) for 7 days, DM-R1: DM treated with RSV (1 mg/kg/day) for 7 days.
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RSV treatment, there was no statistical significance (Fig-
ure 2D). MnSOD protein expression in DM-R0.1 group
was still increased in comparison with normal control.
RSV significantly decreased IL-1b cytokine level but
enhanced TNF-a and IL-6 contents in the diabetic kidney
without the involvement of NF-B signaling pathway
It was observed the content of proinflammatory cytokine
IL-1b significantly increased in the diabetic kidneys in
comparison with the normal controls (Figure 3A). There
was no significant elevation in renal TNF-a and IL-6
cytokine levels in the STZ-DM rats when compared
with the control group (Figure 3B, C). RSV treatment
significantly reduced IL-1b levels in the kidney of DM-
R1 rats when compared to that of the STZ-DM group.
In the diabetic kidneys, however, RSV treatment
remarkably enhanced the proinflammatory cytokine
TNF-a and IL-6 expressions. Renal cytokine TNF-a and
IL-6 levels were also significantly higher in RSV-treated
groups when compared to normal control. It seemed
the NF-B p65 subunit was not contributed to the cyto-
kine expressions because neither the STZ-induced dia-
betic nor the RSV-treated DM rats revealed significant
differences when compared with the non-diabetic con-
trol (Figure 3D).
The antidiabetic effect of RSV on renal tissues had no
remarkable association with MAPK signaling pathway
The diabetic induction significantly increased both
expressions of phosphorylated Erk and p38 proteins
(Figure 4A). Although no statistical significance was
shown, there was an augmentative tendency in JNK acti-
vation in the diabetic kidneys when compared to the
non-diabetic controls. RSV administration in the dia-
betic group did not significantly lower the ratio of Erk
phosphorylation, albeit a decreasing tendency was
shown. There was also no remarkable influence on p38
and JNK phosphorylations in the renal tissues of the
RSV-treated diabetic group in comparison with that of
STZ-DM rats. The ratio of Erk phosphorylation was sig-
nificantly elevated in DM-R0.1 group when compared to
normal control, and that of p38 phosphorylation was
significantly increased in DM-R1 group in comparison
with normal control.
RSV significantly attenuated AMPK signal reduction, with
less attribution to Akt expression, in STZ-induced type 1
diabetic kidneys
A significant reduction in total and phosphorylated
forms of AMPK expressions was observed in the kidneys
of STZ-DM rats (Figure 4B). It was revealed that RSV
treatment significantly increased AMPK phosphorylation
and protein expression in the diabetic kidneys. Though
there was no statistical significance, it was shown that
an increased tendency of Akt phosphorylation and pro-
tein expression in the diabetic kidneys and RSV treat-
ment augmented this tendency. In addition, the renal
expression of phosphorylated Akt was also slightly ele-
vated without significance in the STZ-DM group. Akt
protein expression was significantly increased in RSV-
treated diabetic rats when compared to normal control.
Discussion
In the present study, we claimed that RSV significantly
prevented loss of body weight, lowered plasma glucose
and creatinine concentrations, and increased plasma
insulin level, to moderate extents in the STZ-diabetic
rats. Additionally, RSV remarkably alleviated oxidative
stress and prevented AMPK protein down-regulation
may contribute to its renoprotective effects in the dia-
betic rats. Interestingly, our experimental results further
revealed that RSV significantly reduced the levels of IL-
1b b u te l e v a t e dt h a to fT N F - a and IL-6 in the diabetic
kidney. To our knowledge, this is the first report to
investigate the concurrently suppressive and stimulating
effects of RSV on proinflammatory cytokines in the
renal tissues of diabetes in vivo.
It has been shown that hyperglycemia promoted oxi-
dative stress in nephritic tissues, eventually leading to
renal injury in diabetes. Augmentation of free radicals
and impairment of key antioxidant enzymes were
believed to contribute to the development of DN. The
ameliorative effects of RSV on hyperglycemia-associated
oxidative stress were widely recognized [25]. RSV was
proved to possess an insulin-like property in vivo [19].
Further, there was increasing evidence implicating that
RSV alleviated oxidative stress in a variety of hyperglyce-
mia-affected tissues, including renal [25], neuron [32],
vascular endothelial [33], and pancreatic b cells [34].
One recent study indicated that RSV prevented lipid
peroxidation and increased glutathione contents and
activities of SOD and catalase in STZ-induced diabetic
kidneys [25]. It was also reported that RSV decreased
the generation of reactive oxygen species (ROS) and
nitric oxide in high glucose-exposed porcine renal proxi-
mal tubular cells [35]. However, our results suggested
that RSV partially attenuated hyperglycemia-associated
oxidative injury mediated by reduction of superoxide
anion and protein carbonyl levels, but did not alleviate
lipid peroxidation in renal tissues.
Attraction has been drawn to the correlation between
inflammatory activity and diabetic complications. There
was accumulating evidence indicating that renal inflam-
mation played a key role in the pathogenesis of DN. it
was demonstrated that diabetes increased proinflamma-
tory cytokines including TNF-a,I L - 1 b and IL-6 in the
circulating [36], renal production [37,38], and urinary
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Figure 3 The effects of RSV on IL-1b,T N F - a, IL-6, and NF-B protein expression in the renal tissues of STZ-DM rats.S a m p l e sw e r e
processed to measure IL-1b (A), TNF-a (B), or IL-6 (C) using a competitive ELISA. (D) Equal amounts of proteins were resolved on 10% SDS-PAGE
and blotted with NF-B antibody. The blots were shown at the top and the quantified ratios were shown at the bottom. Results were expressed
as means ± standard error (n = 5 per group). *: P < 0.05 vs. control, †: P < 0.05 vs. STZ-DM, ‡: P < 0.05 vs. DM-R0.1, IL-1b: interleukin 1b, TNF-a:
tumor necrosis factor a, IL-6: interleukin 6, NF-B: nuclear factor kappa B, CON: non-diabetic control, STZ-DM: streptozotocin-induced diabetes,
DM-R0.1: DM treated with RSV (0.1 mg/kg/day) for 7 days, DM-R1: DM treated with RSV (1 mg/kg/day) for 7 days.
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Figure 4 The effects of RSV on Erk, p38, JNK, Akt, and AMPK phosphorylation and total protein expressions in the renal tissues of
STZ-DM rats. Equal amounts of proteins were resolved on 10% SDS-PAGE and blotted with Erk, p-Thr202/Tyr204-Erk, p38, p-Thr180/Tyr182-p38,
JNK, p-Thr183/Tyr185-JNK (A), and Akt, p-Thr308-Akt, AMPK, p-Thr172-AMPK (B) antibodies. The blots were shown at the top and the quantified
ratios were shown at the bottom. Results were expressed as means ± standard error (n = 5 per group). *: P < 0.05 vs. control, †: P < 0.05 vs.
STZ-DM, ‡: P < 0.05 vs. DM-R0.1, CON: non-diabetic control, STZ-DM: streptozotocin-induced diabetes, DM-R0.1: DM treated with RSV (0.1 mg/kg/
day) for 7 days, DM-R1: DM treated with RSV (1 mg/kg/day) for 7 days.
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Page 8 of 10excretion [39]. Our results revealed excessive renal pro-
duction of IL-1b in the early stage of DN. Administra-
tion of RSV significantly inhibited IL-1b elevation in the
diabetic kidneys. RSV treatment, however, elevated
TNF-a and IL-6 levels in the renal tissues of the dia-
betic group. Recently, several researches have proved
that RSV did not suppress but augmented signals
responsible for inflammation in the renal tissues of dia-
betes. Gene and protein expressions of COX, one pros-
taglandin synthase mainly activated in certain
inflammatory conditions, were not suppressed by RSV
treatment in the renal tissues of diabetic rodents [27].
Instead, RSV enhanced NF-B activity in the renal tubu-
lar and mesangial cells exposed to cytokine mixtures
[28]. Although these reports indicated the proinflamma-
tory potential of RSV which was similar to our experi-
mental results, they were contrastive to previous studies
identifying the anti-inflammatory property of RSV in
diabetes. We showed that RSV modulated proinfamma-
tory cytokines but unaffected NF-B signals, implying a
possibility that RSV modulates inflammation mediated
by other existing cascades against cellular stress in DN.
The effects of RSV on renal inflammation in DM remain
to be further elucidated.
Under physiological circumstances, the signaling regu-
lations of cellular energy like insulin cascades were pre-
dominated by both Akt and AMPK. It was
demonstrated that suppression of AMPK was interposed
by hyperglycemia and elevated Akt activity [11]. In addi-
tion, a recent study revealed that reduced phosphoryla-
tion of AMPK appeared to be reversed under RSV
treatment in the diabetic kidney [26]. Our finding sug-
gested that RSV prevented renal AMPK dephosphoryla-
tion and protein down-regulation in insulin-deficient
diabetic rats. It was observed a tendency of increased
Akt phosphorylation in the diabetic kidney, without any
remarkable influence after RSV treatment. Since AMPK
was newly identified as a modulating factor in diabetes-
induced renal injury, RSV treatment may play a novel
role as a therapeutic agent by prevention of AMPK
dephosphorylation and protein down-regulation in
early-stage DN.
Conclusion
In conclusion, the present study provides evidence that
RSV reduced plasma glucose and creatinine, oxidative
stress, proinflammatory cytokines and up-regulated
AMPK proteins in diabetes which may contribute to its
renoprotective effects in the early stage of DN. Interest-
ingly, RSV decreased proinflammatory cytokine IL-1b
but elevated TNF-a and IL-6 levels in renal tissues of
STZ-induced diabetic rats. If and how RSV influences
renal inflammation still remains controversial. RSV
also prevented AMPK protein dephosphorylation and
down-regulation in the insulin-deficient diabetic kidney.
These findings suggest that RSV may serve as one useful
new therapeutic agent in the early stage of DN.
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